Showing results (1411-1420 of 1,560) with videos related to
Sort By:
Pageof 156
BMC Research Notes|November 23, 2017
High-throughput SuperSAGE for gene expression analysis of Nicotiana tabacum-Rhizoctonia solani interactionRoxana Portieles, María Elena Ochagavia, Eduardo Canales, et al.Cancer Science|December 22, 2005
Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate ((90)Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphomaTakashi Watanabe, Shoji Terui, Kuniaki Itoh, et al.Japanese Journal of Radiology|November 9, 2022
Common and uncommon vascular injuries and endovascular treatment associated with pelvic blunt trauma: a real-world experienceRyo Aoki, Kento Nakajima, Yusuke Kobayashi, et al.Plos One|December 31, 2013
QTL map meets population genomics: an application to riceJeffrey A Fawcett, Tomoyuki Kado, Eriko Sasaki, et al.The Journal of Biological Chemistry|May 29, 2002
Disruption of adiponectin causes insulin resistance and neointimal formationNaoto Kubota, Yasuo Terauchi, Toshimasa Yamauchi, et al.The Journal of Biological Chemistry|March 19, 2004
Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) miceRyo Suzuki, Kazuyuki Tobe, Masashi Aoyama, et al.American Journal of Physiology. Endocrinology and Metabolism|January 30, 2009
Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient miceKazutaka Aoki, Junji Matsui, Naoto Kubota, et al.Journal of Viral Hepatitis|August 19, 2007
Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patientsM Yoneda, S Saito, T Ikeda, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2010
Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot studyMasato Yoneda, Koji Fujita, Yuichi Nozaki, et al.The Journal of Biological Chemistry|September 5, 2001
The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistanceT Yamauchi, J Kamon, H Waki, et al.Pageof 156